One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Koji Ariyoshi Biography and Net Worth

VP of Aflac

Koji Ariyoshi serves as Executive Vice President, Director - Marketing and Sales of Aflac Japan of the Company. since 2012. He was First Senior Vice President, Director of Marketing and Sales, Aflac Japan, from 2010 until 2011; Senior Vice President, Deputy Director of Marketing and Sales, Aflac Japan from 2008 until 2009.

What is Koji Ariyoshi's net worth?: The estimated net worth of Koji Ariyoshi is at least $4.11 million as of May 29th, 2019. Ariyoshi owns 49,129 shares of Aflac stock worth more than $4,113,571 as of April 26th. This net worth approximation does not reflect any other assets that Ariyoshi may own. Learn More about Koji Ariyoshi's net worth.
How do I contact Koji Ariyoshi?: The corporate mailing address for Ariyoshi and other Aflac executives is 1932 WYNNTON ROAD, COLUMBUS GA, 31999. Aflac can also be reached via phone at (706) 323-3431 and via email at [email protected]. Learn More on Koji Ariyoshi's contact information.
Has Koji Ariyoshi been buying or selling shares of Aflac?: Koji Ariyoshi has not been actively trading shares of Aflac within the last three months. Most recently, Koji Ariyoshi sold 63,703 shares of the business's stock in a transaction on Wednesday, May 29th. The shares were sold at an average price of $52.20, for a transaction totalling $3,325,296.60. Following the completion of the sale, the vice president now directly owns 49,129 shares of the company's stock, valued at $2,564,533.80. Learn More on Koji Ariyoshi's trading history.
Who are Aflac's active insiders?: Aflac's insider roster includes Daniel Amos (Chairman), Koji Ariyoshi (VP), Steven Beaver (CFO), William Bowers (Director), Frederick Crawford (COO), James Daniels (CFO), Toshihiko Fukuzawa (Director), June Howard (VP), Thomas Kenny (Director), Eric Kirsch (EVP), Georgette Kiser (Director), Masatoshi Koide (Director), Charles Lake, II (Director), Karole Lloyd (Director), Joseph Moskowitz (Director), Albert Riggieri (SVP), Barbara Rimer (Director), Audrey Tillman (EVP), and Teresa White (Insider). Learn More on Aflac's active insiders.
Are insiders buying or selling shares of Aflac?: During the last twelve months, insiders at the financial services provider sold shares 20 times. They sold a total of 354,060 shares worth more than $27,087,634.82. The most recent insider tranaction occured on March, 20th when Director Thomas J Kenny sold 5,000 shares worth more than $423,100.00. Insiders at Aflac own 0.9% of the company. Learn More about insider trades at Aflac.
Information on this page was last updated on 3/20/2024.

Koji Ariyoshi Insider Trading History at Aflac

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/29/2019	Sell	63,703	$52.20	$3,325,296.60	49,129
8/11/2016	Sell	57,413	$73.20	$4,202,631.60	15,956
8/9/2016	Sell	3,886	$73.20	$284,455.20	39,841
12/27/2013	Sell	26,250	$67.20	$1,764,000.00	9,375

Koji Ariyoshi Buying and Selling Activity at Aflac

Aflac Company Overview

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

Today's Range

Now: $83.62

$83.11

$83.79

50 Day Range

MA: $82.61

$78.77

$85.86

2 Week Range

Now: $83.62

$64.10

$86.26

Volume

811,030 shs

Average Volume

2,259,577 shs

Market Capitalization

$48.12 billion

P/E Ratio

10.79

Dividend Yield

2.37%

Beta

0.91

The World's First "$20 Trillion Drug?"

From Behind the Markets | Ad

Get the name of the stock here >>>